Department of Psychiatry

Penn Behavioral Health

faculty photo

Caryn Lerman

John H. Glick, M.D. Professor in Cancer Research
Director, Neuroscience of Behavior Initiative , University of Pennsylvania
Co-Director, Penn Medicine Neuroscience Center, University of Pennsylvania
John H. Glick Professor, University of Pennsylvania
Senior Deputy Director, Abramson Cancer Center, University of Pennsylvania
Vice Dean for Strategic Initiatives, Perelman School of Medicine
Department: Psychiatry
Graduate Group Affiliations

Contact information
Penn Medicine Executive Offices
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-898-2443
Fax: 215-573-2030
B.S. (Psychology)
Pennsylvania State University , 1981.
M.S. (Psychology)
University of Southern California , 1982.
Ph.D. (Clinical Psychology)
University of Southern California , 1984.
(Internship in Clinical/Medical Psychology)
Boston Veterans Administration Medical Center , 1985.
Post-Graduate Training
Intern in Clinical/Medical Psychology, Boston Veterans Administration Medical Center, 1984-1985.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Dr. Lerman's work translates research in neuroscience, pharmacology, genetics, and behavioral science to develop improved interventions for health risk behavior change.

Description of Clinical Expertise

Licensed clinical psychologist

Description of Other Expertise

Teleos Leadership Institute, Certification as Executive Coach

Selected Publications

Kable JW, Caulfield MK, Falcone M, McConnell M, Bernardo L, Parthasarathi T, Cooper N, Ashare R, Audrain-McGovern J, Hornik R, Diefenbach P, Lee FJ, Lerman C: No Effect of Commercial Cognitive Training on Brain Activity, Choice Behavior, or Cognitive Performance. The Journal of Neuroscience 37(31): 7390-7402, 2017.

Falcone M, Cao W, Bernardo L, Tyndale RF, Loughead J, Lerman C: Brain responses to smoking cues differ based on nicotine metabolism rate. Biological Psychiatry 80(3): 190-197, 2016.

Tyndale RF, Zhu AZX, George TP, Cinciripini P, Hawk LW, Schnoll RA, Swan GE, Benowitz NL, Heitjan DF, Lerman C.: Lack of associations of CHRNA5-A3-B4 genetic variants with smoking cessation treatment outcomes in Caucasian smokers despite associations with baseline smoking. PLOS One 10(5): e0128109 2015.

Lerman C, Schnoll, RA, Hawk LW, Cinciripini P, George TP, Wileyto EP, Swan GE, Benowitz NI, Heitjan DF, Tyndale RF, PGRN-PNAT Research Group.: Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. The Lancet Respiratory Medicine 3(2): 131-138, 2015.

Loughead J, Wileyto EP, Ruparel K, Falcone M, Hopson R, Gur R, Lerman C: Working memory-related neural activity predicts future smoking relapse. Neuropsychopharmacology 40(6): 1311-1320, 2015.

back to top
Last updated: 12/20/2017
The Trustees of the University of Pennsylvania
Back to Top